The procedures and steps for registering a Class D medical device under Hong Kong’s Medical Device Administrative Control System (MDACS) are systematic and aligned with international regulatory practices. Below is a detailed, step-by-step guide tailored specifically to Class D medical devices—the highest-risk category, which includes life-sustaining, implantable, or critical devices.
Regulator: Medical Device Division (MDD), Department of Health (DoH), Hong Kong
System: Voluntary registration under MDACS (but functionally required for public hospitals)
Device Class: Class D (highest risk)
Application Mode: Online submission via the MDACS Device Information System (MDIS)
Use the official guidance document TR-003 (for general devices) or TR-006 (for IVDs) to determine your device’s classification.
Class D includes:
Implantable defibrillators
Heart valves
Dialysis systems
Ventilators
Cardiovascular stents
Devices in direct contact with the CNS, heart, or circulatory system
👉 Refer to: TR-003
A Local Responsible Person (LRP) is required if the manufacturer is not based in Hong Kong.
LRP must:
Be a legal entity registered in Hong Kong
Represent the manufacturer in front of MDD
Handle application submission, surveillance, and incident reporting
👉 LRP is a critical point of contact throughout the device lifecycle.
You must compile a comprehensive dossier for Class D devices. This includes:
| Document | Requirement |
|---|---|
| Application Form (MD 1 via MDIS) | Mandatory |
| Declaration of Conformity | Aligned with Essential Principles (GN-01/GN-02) |
| Certificate of Free Sale or Foreign Approval | Must be from a GHTF country (EU, US, Australia, Canada, Japan, etc.) |
| Quality Management System Certificate | ISO 13485:2016 |
| Risk Management Report | Per ISO 14971 |
| Clinical Evaluation Report (CER) | Clinical evidence or literature |
| Technical File Summary | Description of design, materials, software, etc. |
| Device Labeling and IFU | English and/or Traditional Chinese |
| Post-Market Surveillance Plan | AE reporting, vigilance, recall handling |
| Sterilization and Biocompatibility Evidence | If applicable |
| Software Validation | For software-based or software-controlled devices |
👉 Use the Essential Principles Checklist (GN-01) to demonstrate compliance with safety/performance standards.
Since April 2024, all applications must be submitted through the Medical Device Information System (MDIS):
The LRP creates an account on MDIS: https://www.mdd.gov.hk
Uploads documentation and submits the MD-1 form online
No government application fee at this stage (as MDACS is still voluntary)
💡 Note: Paper applications have been phased out since October 2024.
Once submitted, MDD performs the following:
Verifies completeness of documentation
Checks overseas approvals and certificates
May request supplementary information
May reject incomplete/inaccurate submissions
May conduct on-site assessment (rare, but possible)
🕒 Expected Review Time:
Approximately 12–24 weeks, but may vary depending on complexity and completeness
If approved, MDD issues a Listing Certificate and the device is included in the official MDACS Medical Device List.
📌 Key Details:
Validity: 5 years (renewable)
Listing includes: device name, LRP, manufacturer, intended use, and classification
After listing, the LRP must maintain compliance through:
| Activity | Requirement |
|---|---|
| Vigilance Reporting | Adverse events must be reported to MDD |
| Field Safety Corrective Actions (FSCA) | Recalls, product corrections |
| Distribution Records | Maintain traceability |
| Labeling Changes | Notify MDD of major changes |
| Re-listing | Submit renewal before expiration of 5 years |
| Procedure | Details |
|---|---|
| Classification | Confirm Class D via TR-003/TR-006 |
| Appoint Local Responsible Person | Mandatory for foreign manufacturers |
| Prepare Documentation | Technical + regulatory (see above) |
| Submit via MDIS | Online only as of April 2024 |
| Review Period | 3–6 months (varies) |
| Listing Validity | 5 years |
| Post-Market Duties | Vigilance, recall, traceability |
Ensure all overseas regulatory approvals are current and valid (e.g., CE, FDA, TGA).
The Declaration of Conformity should reference MDACS’s Essential Principles.
Submit Chinese and English labeling/IFU.
Ensure your LRP is trained in post-market surveillance responsibilities.
Consider pre-submission consultation with MDD for high-risk innovations.

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn